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3a -Hydroxysteroid Oxidoreductase A ctivities 
in Dihydrotestosterone Degradation and 
Back-formation in Rat Prostate and 
Epididym is
P. N. Span,1 C. G. J. Sweep,2 Th. J. Benraad2 and A. G. H. Sm als1*
department of Medicine, Division of Endocrinology, University Hospital Nijmegen3 The Netherlands and 
2Department of Experimental and Chemical Endocrinology, University Hospital, Nijmegen, The Netherlands
The metabolism o f dihydrotestosterone (DHT) and 5a-androstane-3a,17jS-diol (3a-Adiol) was assessed  
in full homogenates of rat prostate and epididym is. The major de gradational route of DHT was 
catalysed by the enzyme(s) 3a-hydroxysteroid oxidoreductase (HSOR). Enzym e kinetic characteristics 
Vmax> Km and Vmax/Km ratio, were obtained for the NADP(H )- and NAD (H )-dependent interconversion  
of DHT and 3a-Adiol at pH 7.0 and at saturated co-factor concentration. For both the reduction of DH T  
and the oxidation of 3a-Adiol, NAD(H) was the preferred co-factor when activities were rated by their 
Vraax and Vmax/Km ratio. Combining the data with the earlier established Vmnx/Km ratios for the 
5a-reductase isozyme type I and II activities in rat prostate and epididym is indicated that DHT, at 
saturated co-factor concentrations, would not be sustained in either tissue considering the reported  
enzyme characteristics. The reported exclusive bioavailability of the co-factors NADPH  and NAD+ 
in vivo, however, will direct the metabolic pathways in these tissues to sustain the form ation of DHT. 
Copyright ©  1996 Elsevier Science Ltd.
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INTRODUCTION
Growth and development of the rat prostate 
are androgen-dependent, dihydrotestosterone (DHT) 
being the most active androgen. Inhibition of the 
formation of D H T in the rat leads to apoptosis and cell 
death of prostatic cells [1]. This steroid is derived from 
testosterone (T) through 5a-reduction by the NADPH- 
dependent, membrane-bound 5a-reductase (5a-RED, 
E.C. 1.3.99.5) of which two isozymes exist in both rat 
and human [2]. The rat and human isozymes share 
similar pH profiles and affinity constants for several 
substrates [3, 4]. Earlier, our laboratory reported the 
quantification of the type I and type II 5a-RED by 
enzyme activity studies in rat prostate and epididymis
[5].
D H T  is metabolized by several enzymes [6, 7], the 
predominant D H T degrading enzyme in both rat 
prostate and epididymis being cytoplasmatic [8, 9]
(3a-HSOR, E.C. 1.1.1.50). In most male accessory 
3sex tissues* 3/?-HSOR (E.C. 1,1.1.51) only accounts 
for minor D H T  metabolism [7 ,11 ,12]. 3a-HSOR 
is capable both of reducing D H T  (H SO R^) to 5a- 
androstane-3a,17/?-diol (3a-Adiol) and back-oxidizing 
3a-Adiol to D H T  (HSORoJ. Rat prostatic [13] and 
epididymal [14] HSOR enzymes are considered 
optimally active at neutral pH, like both 5a-RED 
subtypes [15].
In the present paper, the N A D P(H )- and NAD(H)- 
dependent HSOR activities were quantified at neutral 
pH  in rat prostate and epididymis tissue homogenates, 
both for the reduction of D H T  to 3a//?-Adiol and the 
back-oxidation of 3a-Adiol to D H T, to get more insight 
into the role of these enzymes in the degradation and 
back-formation of the active androgen DHT.
MATERIALS AND M ETH O DS
and/or nuclear [10] 3 a-hydroxysteroid oxidoreductase Materials
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[l,2 56,7-3H]Testosterone (3.74 TBq/mmol) and 
[la ,2a(n )-3H] 17/?-hydroxy-5a-androstan-3-one (dihy­
drotestosterone, D H T) (2.00 TBq/mmol) were pur­
chased from Amersham (Amersham, U.K.). [9,11-
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3H]5a-androstane-3a,17/?-diol (Adiol) (1.48 TBq/ 
mmol) was obtained from D u Pont-New England 
Nuclear (Boston, MA). All radiolabelled steroids were 
purified by high performance liquid chromatography 
(HPLC) before use. Testosterone was purchased from 
Steraloids (Wilton, N H ). Diethylether (p.a.), n-hexane 
(LiChrosolv) and 2-propanol (LiChrosolv) from Merck 
(Darmstadt, Germany). All other chemicals used were 
of analytical grade.
Tissue preparation
Prostate and epididymis tissues were obtained from 
Wistar rats 7-13 weeks old and processed as described 
earlier [5, 16, 17]. In short, tissues were homogenized 
in a 20 mM phosphate buffer containing 1 mM 
monothioglycerol and 0.25 M  sucrose using a Dounce 
tissue grinder. The homogenate was filtered through 
nylon netting of 50 and 140 mesh, respectively, to 
remove cell debris. The resulting full homogenate was 
used in all further experiments.
Enzyme assays and HPLC
The HSOR enzyme assays and subsequent separation 
of metabolites on HPLC were modified from the assay 
for 5a-RED described earlier [5, 16, 17]. In short, 
tritiated substrate steroids (either 3H -D H T  for H SO R ^ 
or 3H“3«■-Adiol for HSOR^) were isotopically diluted to 
the desired concentration with unlabelled steroid and 
incubated at 37°C in a 200 m M  Tris-citrate buffer 
pH 7.0 with either 2 m M  NADPH or NADH for 
H SO R^, or with either NADP+ or NAD* for HSOR^, 
in a final volume of 1 ml. The metabolites formed were 
extracted with diethylether and dissolved in 100 ¡x\ 
hexane for separation on HPLC. A Hibar LiChrosorb 
Diol column was used with an isocratic flow of 
1.5 ml/min of hexane-propanol 96:4 (v/v). Radio­
activity was monitored using a Flo One Beta Radiomatic 
A500 radio-chromatography detector. The percentile 
formation of either D H T  or 3a//J-Adiol was measured 
to estimate initial velocities.
Calculation of enzyme characteristics
Initial velocities were estimated against a substrate 
concentration range of 50 nM  to 3.2 /¿M, and Km and 
Vmax were calculated by computerized fitting (Enzfitter 
program) of the data using a non-linear regression 
procedure based on the Michaelis-Menten equation. 
Eadie-S cat chard plots of obtained initial velocity 
estimates were applied [5, 17]. The Vmax/Km ratio, used 
in this paper, can be considered a measure of enzyme 
activity at low (physiological) substrate concentrations, 
as at [S ]« K m, the Michaelis-Menten equation can be 
simplified to v = Vraax/Km* [S].
RESULTS
Maximum velocity (Vmax) and apparent affinity 
constant (Km) values for HSOR activities were
established from Eadie-Scatchard plots of the obtained 
estimated initial velocities in rat prostate and epididymis 
homogenates (Fig. 1). These values were obtained for 
the reduction of D H T to 3a//J-Adiol (HSORrcd), as well 
as for the back conversion of 3a-Adiol to DHT 
(HSORox). Results were obtained at pH 7.0 for both 
NAD(H)- and NADP(H)~dependent metabolism at 
saturated (2 mM) co-factor concentrations.
For each of the NADP(H)- or the NAD(H)- 
dependent activities^ the Vmax values were approximately 
similar for both the reductive and oxidative pathways of 
HSOR in rat prostate as well as in epididymis (Table 1). 
The values for NADH-dependent HSORred
were approximately 10-fold higher than the NADPH- 
dependent reductions in both tissues. The Vmax for 
NAD+~dependent HSORoX was also more than 10-fold 
higher than the Vmax for NADP+-dependent oxidation in 
the rat prostate. In die rat epididymis, however, the Vmax 
ratio of NADP4*- and NAD+~dependent oxidation was 
only a factor 3. The affinity constants for the NADPH- 
and NADH-dependent HSORr^ activities in both 
tissues were about 0.5-0.7 fiM, The KmS for HSOR™ 
were higher (approx. 0,8-7.3 ¿¿M).
The efficiency ratios Vmax/Km were established from 
the ordinate intercepts of the Eadie-Scatchard plots 
(Table 2), In both rat tissue homogenates the 
NAD(H)-dependent HSOR efficiency ratios were many 
times (7-18) higher than the NADP(H)-dependent 
activities at low substrate concentrations. In an earlier 
paper the Vmax/Km ratios for 5a-RED isozyme type I and 
type II activities in rat prostate and epididymis were 
described [5]. Total 5a-RED (type I and type II) 
V^/Kni values are presented in Table 2 for purposes of 
comparison. 5a-RED activity is completely dependent 
on NADPH as co-factor.
Of the enzyme activities we have measured in the rat 
prostate and epididymis, both 5a-RED isozymes and 
HSOR^ contribute to the formation of DHT, whereas 
HSORred degrades D H T to Adiol. Comparison of the 
Vmax/Km values of 5cc-RED and HSORoX with HSORred 
in Table 2 approximates relative DHT-forming and 
degrading activities at low substrate concentrations.
Total HSOIU-activity (NADPH- and NADH- 
dependent) exceeds 5a-RED activity by more than 
80-fold in rat prostate. In rat epididymis, the total 
5a-RED activity found was much higher than in the 
prostate and total HSORred potential in vivo activity 
exceeded total 5a-RED activity only approximately by 
a factor of 2 in this tissue. The ratio of the metabolism 
of D H T  to Adiol (HSORjed) over the back-conversion 
from 3a-Adiol to D H T (H SO R J was approximately
2.4 and 5.9 in rat prostate and epididymis, respectively. 
Total potential in vivo DHT-degrading activity (Vmax/Km 
of H SO R ^) was 2354 and 608 /il/(min*mg protein) 
in rat prostate and epididymis, respectively, whereas 
the total Vmax/Km values of DHT-forming activities 
(total 5<x~RED and HSOR^) were 996 and 366 jul/ 
(min*mg protein), respectively (Fig. 2 A and
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Fig, l.Eadie-Scatchard plots of HSOR activities obtained in (A) rat prostate and (B) rat epididym is homogenates. 
Initial velocities were estimated for the reduction o f DHT to Adiol (HSOR«d) (subfigures a and c) and the 
oxidative back formation of DHT from 3a-Adiol (HSOR^) (subfigures b and d). Both the N A D P (H )- (subfigures 
a and b) and NAD(H)-dependent (subfigures c and d) activities were assessed. In this plot, the abscissa intercept 
denotes the maximum velocity, Vmw whereas the ordinate intercept denotes potential in vivo  activity, Vmnx/Km.
The slope in this plot equals -  1/K,■ m *
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Vmax and K m values for H S O R reà and H S O R ox in rat prostate and epididymis
Tissue Co-factor H S O R ^ HSORox
Vmax pmol/(rrdn*mg protein) K m nM Vmax pmol/(min*mg protein) Km nM
Prostate NADP(H) 96 614 54 1090
NAD(H) 1110 505 716 781
Epididymis NADP(H) 51 645 94 7331
NAD(H) 384 726 275 3042
Both the NADP(H)- and NAD(H)-dependent activity kinetic characteristics were determined in homogenates at pH 7,0 as also shown in 
Fig. 1.
2C). So, at pH  7.0* the potential in vivo activity, as 
measured by the Vmax/Km ratio, of degradation of D H T
HSOI^cd activity ascertained in the present study, 
indicating that most probably only 3a-HSOR activity 
to Adiol predominated over the formation of D H T  from was measured. According to the literature, in most 
T  and the oxidative back-conversion from 3a-Adiol at male accessory sex tissues, including the rat prostate, 
saturated (2 mM) co-factor concentrations in both 3/i-HSOR only accounts for minor D H T metabolism 
tissue homogenates (Fig, 2). However, when only the [7, 11, 12]. 3/J-HSORrgd activity is reportedly mainly 
NADPH- and NAD*’-dependent activities were com- located in the dorsal and lateral prostate and is not 
pared, considering the exclusive bioavailablity of these detectable in the ventral lobe [7, 12, 18]. In total rat 
co-factors in vivo (vide infra), D H T  accumulation prostate homogenate 3^-HSOR activity might thus 
would be sustained in both tissues (Fig. 2B and D). have been under the detection limit of our assay. Finally,
as the Eadie-S cat chard plots of HSOR activities were
D ISC U SSIO N
In this study the reduction of D H T  to Adiol and the 
back-oxidation of 3a-Adiol to D H T  was investigated
basically linear, the conclusion seems to be justified that 
we have measured a single enzyme activity, most 
probably 3a-HSOR. The HSOR^ activities were 
measured with tritiated 3a-Adiol as substrate and are
in rat prostate and epididymis homogenates. These therefore attributable only to 3a-HSORt)X.
steps in testosterone metabolism are performed by In the present study, an approximately 10-fold higher
multiple isozymes of 3 a -an d  3/?-hydroxysteroid-oxido- VmflX was ascertained for the NAD(H)-dependent 
reductase (HSOR). There are ample reports about the activities of both HSORred and HSORox than for the 
presence and co-factor dependency of these enzymes in NADP(H)-dependent activities. The NAD+-dependent 
both rat prostate [7, 10, 12, 18, 19] and epididymis HSOR^ activity in the rat epididymis, however, was
only three times the value of the NADP+-dependent 
HSORox. These data are seemingly at variance
[9, 14, 20,21],
In our hands, formation of 3/?-Adiol was not 
detected, but the possibility could not be unequivocally with some earlier reports that indicated NADP(H)- 
excluded that 3a- and 3ƒ?-Adiol epimeres were not dependent HSOR activity to be greater than the 
separated with the applied HPLC system. However, in NAD(H) activity in rat prostatic cytosol [8,13].
However, when only the ventral prostate was assessedall experiments only a single Adiol peak was detected 
which eluted with the same retention time as tritiated (800 x g  supernatant), the NAD(H)-dependent HSOR
3a-Adiol. When the mobile phase was changed to activity was found to exceed the NADP(H)-dependent 
hexane/propanol 98:2 v/v, thereby more than doubling activity [7,12]. Furthermore, in the rat prostate a 
the retention times, still no additional peaks could be nuclear-bound NADH-dependent HSORred activity has
detected. Furthermore, the affinity constants found 
in the rat prostate and epididymis homogenate for 
HSORred (approx. 0,5-0.7 piM) and HSOR^ (0.8- 
7.3 ¿¿M) were comparable to those found in literature 
for 3a-HSOR activity [8, 10, 18, 19]. The affinity
been reported, being 20-fold higher than NADPH-
Two distinct 3a-HSORdependent [10].activity
activities have been found in the rat pituitary, one
cytosolic preferring NADPH, another membrane-
bound with NADH as co-factor [22, 23]. As in the
constant reported for rat prostatic 3/3-HSOR activity, present study a full homogenate was used, differences
25.4 fxM [18], is quite different from the Kms of between our study and those in the literature might be
Table 2. Vm(lx!Km ratios (¡ill(min*mg protein)) for rat prostate and epididymis homogenates o f the enzymes 3a-hydroxysteroid- 
oxidoreductase, the reductive (H S O R reä)  and oxidative (H S O R ox)  pathway, and 5<x~reductase type I  and I I  (5&-RED) [5]
Tissue Co-factor HSORred HSORox 5a-RED
Prostate NADP(H) 156 50 29
NAD (H) 2198 917 ------
Epididymis NADP(H) 79 13 263
NAD(H) 529 90
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Fig. 2. Potential in vivo activities (Vma*/Km in jil/(min*mg protein)) obtained in rat prostate (A and B) and in rat 
epididymis (C and D) homogenates. Left bars in each subfigure denote DHT-degrading enzym e activities 
(HSORred)» right bars denote DHT-forming activities (total Sa-RED and HSOR<lx). A and C: All enzym e activities 
(NADP(H)- and NAD(H)-dependent) reported in this paper obtained as described in  the M aterials and M ethods 
section. B and D: NADPH- and NAD+-dependent enzyme activities, thus DHT m etabolism  at “in v ivo ” cellular
cofactor concentrations: NADPH ^  N A D P-1- and NAD* NADH.
due to the experimental protocol applied: unlike in our 
study* in many others cytosolic fractions were used or 
homogenates were centrifuged at 800 xg , leading to the 
loss of any nuclear- or membrane-bound NADH- 
dependent HSOR activity.
HSORox activity has been reported to exceed that 
of HSORred both for their maximum velocities in the 
ventral prostate [7]* as for enzyme activities in cell 
cultures at low substrate concentrations (50 nM) [6]. 
Unlike in the former study* the Vmwf values for both 
HSORred and HSORqX activities reported in the present 
paper for whole prostate homogenates were approxi­
mately similar* which is more in line with recent data 
reported for the ventral prostate [12]. However* due to 
the lower affinity for the back conversion of 3a-Adiol to 
DHT, the total enzyme efficiency ratios (Vmax/Km) 
reported here favoured degradation of D H T at low (i.e. 
physiological) substrate concentrations. The activities 
at these low substrate concentrations* as reported by 
Orlowski and Clark [6]* should be comparable with our 
Vmax/Km ratios* as this ratio indicates enzyme activity at 
[S] «Km [24]. However* in the study of Orlowski and
Clark a cell culture was used where no co-factor was 
added* whereas our results were obtained at saturating 
co-factor concentrations. The difference between our 
study and theirs might in fact be attributable to the 
limited bio avail ability of co-factor in mammalian cells 
[25* 26] (vide infra).
The results presented in this paper do not favour the 
accumulation of D H T  in rat prostate. The high 
HSORred Vmnx/Km ratios indicated a higher tissular 
3a-Adiol concentration under steady-state conditions 
(Fig. 2A). The V^/K™ ratios for HSOR^* HSORox and 
total 5a-RED obtained in the rat epididymis also do not 
favour the accumulation of D H T  (Fig. 2C). Report­
edly* however* tissular co-factor concentrations in vivo
are NADPH > NADP* and NAD+ > NADH 
[25* 26], These relative concentrations would therefore 
favour the reduction of D H T  by the NADPH- 
dependent HSOR^d and the back oxidation by the 
NAD+-depe-dent HSORox. This profoundly changes 
the interpretation of our results (Fig. 2). As the 
NAD(H)-dependent HSOR activities were much 
higher than the NADP(H)-dependent activities* the in
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vivo cellular co-factor concentrations would favour 
D H T formation^ in sharp contrast to results obtained 
at saturated co-factor concentrations in vitro. Early 
reports about the in vivo injection of tritiated androgens 
indeed showed an accumulation of 3H -D H T in the rat 
prostate [27-29] 3 but an accumulation of tritiated 
3a-Adiol in the epididymis [29]. The latter observation 
might indicate that the tissular co-factor concentrations 
in rat epididymis are different from those in the prostate 
and from those generally assumed in vivo. These results 
indicate that a small amount of NADH will lead to 
extensive degradation of DHT^ because of the high 
NADH-dependent H S O R ^ capacity of these tissues. 
Thus, NAD(H) may serve as a potent regulatory factor 
in the degradation and back formation of D H T in these 
rat tissues^ as has been proposed for NADPH in the 
human (hyperplastic) prostate [30].
In summary^ in this paper reductive and oxidative 
3a-HSOR activities have been described in rat prostate 
and epididymis homogenates. Both the NADP(H)- and 
NAD(H)-dependent HSOR activities were assessed. 
Comparison of the enzyme activities involved in 
formation and degradation of D H T  in these tissues^ 
indicated that D H T  concentration would not be 
sustained in either tissue at saturated co-factor 
concentrations. Exclusive bio availability of the co­
factors NADPH and NAD+ in intact cells in vivo, 
however, would direct the metabolic pathways in these 
tissues to the formation of DHT.
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